Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation
Public ClinicalTrials.gov record NCT00431782. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Multi-Center Study of ATI-5923 for Anticoagulation in Patients With Atrial Fibrillation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study (CLN-504) is to determine the safety and develop a dosing regimen of an investigational anticoagulant drug (ATI-5923) in patients with atrial fibrillation.
Study identification
- NCT ID
- NCT00431782
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- Not listed
- Completion
- Sep 30, 2007
- Last update posted
- Nov 7, 2007
2006 – 2007
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ARYx Investigational Site | Anaheim | California | — | — |
| ARYx Investigational Site | Yuba City | California | — | — |
| ARYx Investigational Site | Deerfield Beach | Florida | — | — |
| ARYx Investigational Site | Winfield | Illinois | — | — |
| ARYx Investigational Site | Oklahoma City | Oklahoma | — | — |
| ARYx Investigational Site | Wellsboro | Pennsylvania | — | — |
| ARYx Investigational Site | Wynnewood | Pennsylvania | — | — |
| ARYx Investigational Site | Greer | South Carolina | — | — |
| ARYx Investigational Site | Spartanburg | South Carolina | — | — |
| ARYx Investigational Site | Memphis | Tennessee | — | — |
| ARYx Investigational Site | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00431782, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2007 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00431782 live on ClinicalTrials.gov.